We also analyzed the relationship of SPON2 expression with the disease-free survival of CRC patients and found that upregulation of SPON2 also predicted worse outcome of CRC patients (Log-rank test = 4.935, p = 0.026) (Figure 3B). The gene discussed is SPON2; the disease is colorectal carcinoma.